Schedule 13G ownership disclosure
Arch Therapeutics, Inc.
Security class unavailable · CUSIP: 03939W109
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.5800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001445866-20-000063
- Form type
- SC 13G
- Filer
- Arch Therapeutics, Inc.
- CIK
- CIK 1537561
- Filed
- Jan 23, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership